Simplex Trading
TCRT icon

Simplex Trading’s Alaunos Therapeutics TCRT Stock Holding History

Simplex Trading’s Portfolio TCRT Stock Details TCRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,880
Closed -$33K – 9562
2024
Q2 		$33K Sell
4,880
-460
-9% -$5.49K ﹤0.01% 6484
2024
Q1 		$96K Buy
5,340
+3,648
+216% +$72.9K ﹤0.01% 5628
2023
Q4 		$2K Sell
1,692
-23
-1% -$277 ﹤0.01% 8358
2023
Q3 		$33K Buy
1,715
+760
+80% +$32.7K ﹤0.01% 6183
2023
Q2 		$73K Sell
955
-494
-34% -$40K ﹤0.01% 5446
2023
Q1 		$136K Sell
1,449
-214
-13% -$20.4K ﹤0.01% 4798
2022
Q4 		$161K Sell
1,663
-649
-28% -$94.1K ﹤0.01% 4503
2022
Q3 		$596K Buy
2,312
+1,407
+155% +$409K ﹤0.01% 3262
2022
Q2 		$168K Buy
905
+288
+47% +$27.5K ﹤0.01% 4842
2022
Q1 		$60K Sell
617
-597
-49% -$76.6K ﹤0.01% 6889
2021
Q4 		$8K Buy
1,214
+776
+177% +$171K ﹤0.01% 9224
2021
Q3 		$179K Buy
438
+49
+13% +$15K ﹤0.01% 5777
2021
Q2 		$154K Buy
389
+387
+19,350% +$181K ﹤0.01% 6096
2021
Q1 		$131K Sell
2
-10
-83% -$6.23K ﹤0.01% 5368
2020
Q4 		$446K Buy
12
+9
+300% +$3.58K ﹤0.01% 3580
2020
Q3 		$117K Sell
3
-3
-50% -$1.32K ﹤0.01% 4730
2020
Q2 		$318K Sell
6
-1
-14% -$446 ﹤0.01% 3457
2020
Q1 		$241K Buy
7
+2
+40% +$1.03K ﹤0.01% 3378
2019
Q4 		$372K Sell
5
-4
-44% -$2.75K ﹤0.01% 3052
2019
Q3 		$593K Buy
9
+4
+80% +$3.17K ﹤0.01% 2437
2019
Q2 		$413K Buy
5
+3
+150% +$2.06K ﹤0.01% 2751
2019
Q1 		$95K Sell
2
-11
-85% -$4.6K ﹤0.01% 4382
2018
Q4 		$365K Buy
13
+12
+1,200% +$4.74K ﹤0.01% 2517
2018
Q3 		$40K Sell
1
-1
-50% -$429 ﹤0.01% 5381
2018
Q2 		$84K Buy
2
+1
+100% +$634 ﹤0.01% 4484
2018
Q1 		$7K Sell
1
-2
-67% -$1.25K ﹤0.01% 4377
2017
Q4 		$13K Hold
3
– – ﹤0.01% 3692
2017
Q3 		$7K Sell
3
-2
-40% -$1.78K ﹤0.01% 4127
2017
Q2 		$14K Hold
5
– – ﹤0.01% 3674
2017
Q1 		$61K Buy
5
+1
+25% +$931 ﹤0.01% 2190
2016
Q4 		$40K Sell
4
-4
-50% -$3.6K ﹤0.01% 2386
2016
Q3 		$76K Buy
8
+2
+33% +$1.61K 0.01% 1760
2016
Q2 		$52K Sell
6
-1
-14% -$1.09K ﹤0.01% 2024
2016
Q1 		$56K Buy
7
+2
+40% +$2.05K ﹤0.01% 1871
2015
Q4 		$82K Sell
5
-1
-17% -$1.65K 0.01% 1514
2015
Q3 		$166K Buy
6
+1
+20% +$1.65K 0.01% 1044
2015
Q2 		$300K Sell
5
-3
-38% -$4.66K 0.03% 585
2015
Q1 		$585K Buy
8
+7
+700% +$10.4K 0.07% 277
2014
Q4 		$28K Buy
+1
New +$531 ﹤0.01% 1804

Other funds holding TCRT

MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
SWM
Sugarloaf Wealth Management Duluth, Georgia $529M AUM 14.14% 1-Year Est. Return

Simplex Trading's TCRT Position: Q3 2024 in Review

Simplex Trading sold out of Alaunos Therapeutics (TCRT) in Q3 2024, closing a stake of 27 shares.

Simplex Trading first reported a position in TCRT in Q2 2015 and held it in 34 quarters. The position peaked at $449K in Q4 2015. 29 funds tracked by Wall St. Rank hold TCRT as of Q3 2024.

  • Simplex Trading reported no remaining Alaunos Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Simplex Trading sold 27 Alaunos Therapeutics shares in Q3 2024.
  • Simplex Trading first reported a position in Alaunos Therapeutics in Q2 2015 and held it in 34 quarters.
  • Simplex Trading's Alaunos Therapeutics position peaked at $449K in Q4 2015.
  • 29 funds tracked by Wall St. Rank held Alaunos Therapeutics as of Q3 2024.

Based on Simplex Trading's 13F filing for Q3 2024, filed 8 Nov 2024.